Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)

Sramana Mitra: Talk about your business model. Your doctors are your end customers? Sungwon Lim: Yes. Sramana Mitra: Is it a subscription service or a diagnostic model? Sungwon Lim: We charge per service order. Our customers are hospitals and veterinarian oncologists. We sell our service to them and they add their own margin to the

Read Full Article »

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

Sramana Mitra: What is the dataset? Across all these categories, how many drugs and treatments are we talking about that you have modeled and have data for? Sungwon Lim: Our first service which we commercialized last year is for dog blood cancer. What we are trying to do is help doctors make decisions. The 16

Read Full Article »

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)

Wonderful story of cutting edge application of AI in cancer treatment. Sramana Mitra: Let’s start by introducing our audience to yourself, a bit of your background, and then ImpriMed.